Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids

Immunology Letters

Volumn 93, Issue 2-3, 2004, Pages 227-232

  Bednarek, Janusz ^a   Wysocki, Henryk ^a   Sowiński, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antioxidants; Autoimmune thyroid disease; Corticosteroids; Graves' ophthalmopathy; Oxidative stress

Indexed keywords

CATALASE; CERULOPLASMIN; CORTICOSTEROID; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; LEVOTHYROXINE; LIPID HYDROPEROXIDE; METHYLPREDNISOLONE; PREDNISONE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; THIAMAZOLE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CELL INFILTRATION; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENDOCRINE OPHTHALMOPATHY; ENZYME ACTIVITY; EUTHYROIDISM; FEMALE; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; AUTOANTIBODIES; CATALASE; CERULOPLASMIN; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GRAVES DISEASE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, THYROTROPIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 2442683844     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.03.020     Document Type: Article

References (45)

1. Mariotti S, Pinchera A. Role of the immune system in the control of the thyroid function. In: Greer MA, editor. The thyroid gland. New York: Raven Press; 1990. p. 45-60.
2. Bahn R.S., Garrity J.A., Bartley G.B., Gorman C.A. Diagnostic evaluation of Graves' ophthalmopathy. Endocrinol. Metab. Clin. North Am. 17:1988;527-545
3. Bahn R.S., Dutton C.M., Natt N., Joba W., Spitzweg C., Heufelder A.E. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 83:1998;998-1002
4. Perros P., Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillière's Clin. Endocrinol. Metab. 9:1995;115-135
5. Korducki J.M., Loftus S.J., Bahn R.S. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest. Ophthalmol. Vis. Sci. 33:1992;2037-2042
6. Bahn R.S., Heufelder A.E. Pathogenesis of Graves' ophthalmopathy. N. Engl. J. Med. 329:1993;1468-1475
7. Halliwell B., Gutteridge J.M. Role of free radicals in human disease: an overview. Methods Enzymol. 186:1990;1-85
8. Ahsan H., Ali A., Ali R. Oxygen free radicals and systemic autoimmunity. Clin. Exp. Immunol. 131:2003;398-404
9. Weetman A.P., Holt M.E., Campbell A.K., Hall R., McGregor A.M. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br. Med. J. (Clin. Res. Ed.). 288:1984;518-520
10. Burch H.B., Barnes S., Nagy E.V., Sellitti D., Burman K.D., Bahn R.S., Lahiri S. Immunodetection of manganese superoxide dismutase in cultured human retroocular fibroblasts using sera directed against the thyrotropin receptor. J. Endocrinol. Invest. 21:1998;48-55
11. Burch H.B., Lahiri S., Bahn R.S., Barnes S. Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy. Exp. Eye Res. 65:1997;311-316
12. Heufelder A.E., Wenzel B.E., Bahn R.S. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblast. J. Clin. Endocrinol. Metab. 74:1992;737-742
13. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Lond.). 94:1998;557-572
14. Baxter JD, Tyrrell JB. The adrenal cortex. In: Felig P, Baxter JD, Broadus AE, Frohman LA, editors. Endocrinology and metabolism. New Jork: McGraw Hill; 1987. p. 511-650.
15. Whitehouse M.W., Cleland L.G. Reactive oxygen species and drug therapy for inflammatory disease. Agents Action. 17:1985;173-177
16. Szefler S.J., Norton C.E., Ball B., Gross J.M., Aida Y., Pabst M.J. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming. J. Immunol. 142:1989;3985-3992
17. Majori M., Vachier I., Godard P., Farce M., Bousquet J., Chanez P. Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. Eur. Respir. J. 11:1998;133-138
18. Umeki S., Soejima R. Hydrocortisone inhibits the respiratory burst oxidase from human neutrophils in whole-cell and cell-free systems. Biochim. Biophys. Acta. 1052:1990;211-215
19. Roshol H., Skrede K.K., Aero C.E., Wiik P. Dexamethasone and methylprednisolone affect rat peritoneal phagocyte chemiluminescence after administration in vivo. Eur. J. Pharmacol. 286:1995;9-17
20. Youssef A.A., Baron D.N. Leucocyte superoxide dismutase in rheumatoid arthritis. Ann. Rheum. Dis. 42:1983;558-562
21. Werner S.C. Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the America Thyroid Association. J. Clin. Endocrinol. Metab. 44:1977;203-204
22. Mourtis M., Koorneef L., Wiersinga W.M., Prummel M.F., Berghout A., Gaag R.D. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73:1989;639-644
23. Hoh H.B., Laitt R.D., Wakeley C., Kabala J., Goddard P., Potts M.J., Harrad R.A. The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease. Eye. 8:1994;506-510
24. 2 and 3, 3′, 5, 5′-tetramethylbenzidine. J. Clin. Chem. Clin. Biochem. 23:1985;453-460
25. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310
26. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220:1994;403-409
27. Roos D., Weening R.S., Voetman A.A., van Schaik M.L., Bot A.A., Meerhof L.J., Loos J.A. Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood. 53:1979;851-866
28. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta. 196:1991;143-151
29. Ravin H.A. An improved colorimetric enzymatic assay of ceruloplasmin. J. Lab. Clin. Med. 58:1961;161-168
30. Korda M.M. Status of the antioxidant, monooxygenase and humoral immune system of the body in d-galactosamine hepatitis. Ukr. Biokhim. Zh. 68:1996;72-75
31. Koltuksuz U., Uz E., Ozen S., Aydinc M., Karaman A., Akyol O. Plasma superoxide dismutase activity and malondialdehyde level correlate with the extent of acute appendicitis. Pediatr. Surg. Int. 16:2000;559-561
32. Perrin-Nadif R., Auburtin G., Dusch M., Porcher J.M., Mur J.M. Blood antioxidant enzymes as markers of exposure or effect in coal miners. Occup. Environ. Med. 53:1996;41-45
33. Orem A., Yandi Y.E., Vanizor B., Cimsit G., Uydu H.A., Malkoc M. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet's disease. Clin. Biochem. 35:2002;217-224
34. Fernandez V., Barrientos X., Kiperos K., Valenzuela A., Videla L.A. Superoxide radical generation, NADPH oxidase activity and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: Relation to lipid peroxidation. Endocrinology. 117:1985;496-501
35. Weetman A.P., Holt M.E., Campbell A.K., Hall R., McGregor A.M. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br. Med. J. (Clin. Res. Ed.). 288:1984;518-520
36. Wilson R., Buchanan L., Fraser W.D., Jenkins C., Smith W.E., Reglinski J. Evidence for carbimazole as an antioxidant. Autoimmunity. 27:1998;149-153
37. Ozdem S., Aliciguzel Y., Ozdem S.S., Karayalcin U. Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients. Pharmaclogy. 61:2000;31-36
38. Satici A., Guzey M., Gurler B., Vural H., Gurkan T. Malondialdehyde and antioxidant enzyme levels in the aqueous humor of rabbits in endotoxin-induced uveitis. Eur. J. Ophthalmol. 13:2003;779-783
39. Oldenburg B., van Kats-Renaud H., Koningsberger J.C., van Berge Henegouwen G.P., van Asbeck B.S. Chemiluminescence in inflammatory bowel disease patients: a parameter of inflammatory activity. Clin. Chim. Acta. 310:2000;151-156
40. Das U.N., Mohan I.K., Raju T.R. Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. Prostaglandins Leukot. Essent. Fatty Acids. 65:2001;197-203
41. Clemens M.C., Waller H.D. Lipid peroxidation in erythrocytes. Chem. Phys. Lipids. 45:1987;251-268
42. Maral J., Puget K., Michelson A.M. Comparative study of superoxide dismutase activity, catalase and glutathione peroxidase levels in erythrocytes of different animals. Biochem. Biophys. Res. Commun. 77:1977;1525-1535
43. Perros P., Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillière's Clin. Endocrinol. Metab. 9:1995;115-135
44. Hildebrandt G., Seed M.P., Freemantle C.N., Alam C.A., Colville-Nash P.R., Trott K.R. Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int. J. Radiat. Biol. 74:1998;367-378
45. Bartalena L., Pinchera A., Marcocci C. Management of Graves': reality and perspectives. Endocr. Rev. 21:2000;168-199